|
Research Management and Support
|
RMS2009 [E]
|
$350,982,837
|
$1,593,158
|
N/A
|
National Cancer Institute
|
|
Hormone-Related Cancers
|
ZIA CP010126-10302
|
$147,334
|
$73,667
|
A Brinton, Louise
|
DCEG (NCI)
|
|
Hormone-Related Cancers
|
ZIA CP010126-10495
|
$8,315
|
$4,157
|
A Brinton, Louise
|
DCEG (NCI)
|
|
MMC and VICC: Partners in Eliminating Cancer Disparities
|
5U54CA091408-09
|
$1,475,007
|
$442,502
|
Adunyah, Samuel
|
MEHARRY MEDICAL COLLEGE
|
|
Role of Mitochondrial Genomic Alterations in Epithelial Ovarian Tumors
|
1SC2CA150317-01A2
|
$140,000
|
$140,000
|
Aikhionbare, Felix
|
MOREHOUSE SCHOOL OF MEDICINE
|
|
Vitamin D Pooling Project
|
ZIA CP010195-10436
|
$398,953
|
$63,833
|
Albanes
|
DCEG (NCI)
|
|
Clinical Academic Oncologist Training Program
|
5K12CA087718-10
|
|
$0
|
Albertini, Mark
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
2P30CA023074-31
|
$4,161,907
|
$1,123,715
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-31S1
|
$105,806
|
$28,568
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$728,095
|
$72,809
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Children's Oncology Group Statistics and Data Center Grant
|
5U10CA098413-07
|
$5,725,544
|
$114,511
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
SEER Special Studies
|
ZIA CP010183-10316
|
$161,094
|
$64,437
|
Anderson
|
DCEG (NCI)
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENING
|
N01CN025516-095
|
$1,562,516
|
$390,629
|
ANDRIOLE, GERALD
|
WASHINGTON UNIV:1107522
|
|
Extension of Radiotherapy Research
|
3P01CA006294-44S1
|
$300,000
|
$30,000
|
ANG, K
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Nuclear Factor-kappaB in Ovarian Cancer
|
ZIA BC 011054
|
$486,109
|
$486,109
|
Annunziata, Christina
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
ZIA SC 010379
|
$279,762
|
$55,952
|
Aplan, Peter
|
CCR (NCI)
|
|
Tumor Suppressor Protein, p53
|
ZIA BC 005599
|
$309,113
|
$154,557
|
Appella, Ettore
|
CCR (NCI)
|
|
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
|
ZIA BC 011197
|
$309,113
|
$154,557
|
Appella, Ettore
|
CCR (NCI)
|
|
Role of Src in Stress-Mediated Progression of Ovarian Cancer
|
5F31CA126474-03
|
$27,032
|
$27,032
|
ARMAIZ-PENA, GUILLERMO
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Inflammatory Markers in Circulation and Ovarian Cancer Risk
|
5R21CA116585-02
|
$190,688
|
$190,688
|
Arslan, Alan
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
ADD ARTICLE H.49., EXCHANGE OF CONFIDENTIAL INFORMATION AND RESEARCH MATERIALS
|
N01CO800001-012
|
$231,187,932
|
$692,000
|
ARTHUR, LARRY
|
SAIC-FREDERICK INC:1107088
|
|
Structural Basis of Multidrug resistance in Cancer
|
5K01CA113486-05
|
$155,422
|
$38,856
|
ASOJO, OLUWATOYIN
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
ENGINEERED INTELLIGENT MICELLE FOR TUMOR pH TARGETING
|
2R01CA101850-05A1
|
$271,181
|
$135,591
|
Bae, You
|
UNIVERSITY OF UTAH
|
|
Micelle surface engineering for active targeting by acidic tumor extracellular pH
|
5R01CA122356-04
|
$257,668
|
$85,030
|
Bae, You
|
UNIVERSITY OF UTAH
|
|
Autocrine Wnt signaling in human breast and ovarian cancer cells
|
7R01CA121119-03
|
$205,200
|
$102,600
|
Bafico, Anna
|
CARDIFF UNIVERSITY
|
|
Vitamin D and Ovarian Cancer Prevention and Treatment
|
5R01CA111334-05
|
$244,382
|
$244,382
|
BAI, WENLONG
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Pharmacokinetic strategies to optimize IP chemotherapy
|
5R01CA118213-04
|
$255,967
|
$255,967
|
BALTHASAR, JOSEPH
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
CD4+ Memory T-Cells in Human Lung Tumor Micorenvironment
|
5R01CA108970-05
|
$290,964
|
$29,096
|
BANKERT, RICHARD
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Re-activating Memory T Cells in the Microenvironment of Human Tumors
|
5R01CA131407-02
|
$345,888
|
$345,888
|
BANKERT, RICHARD
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Optical Imaging of Ovarian Carcinogenesis in a Rat Menopause Model
|
5R01CA119200-03
|
$282,735
|
$282,735
|
Barton, Jennifer
|
UNIVERSITY OF ARIZONA
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
3P50CA083639-09S1
|
$57,442
|
$57,442
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
3P50CA083639-10S1
|
$141,526
|
$141,526
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
5P50CA083639-10
|
$2,001,032
|
$2,001,032
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
LSPR Nanosensor for Simplified Clinical Assays
|
5R44CA108017-03
|
$537,299
|
$537,299
|
Bastiaans, Glenn
|
INTELLIGENT OPTICAL SYSTEMS, INC.
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$109,331
|
$10,933
|
Bates, Susan
|
CCR (NCI)
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-25
|
$1,884,250
|
$75,370
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
Splicing factors as therapeutic targets for the treatment of ovarian cancer
|
1R01CA138762-01
|
$314,066
|
$314,066
|
BECK, WILLIAM
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
The role of Toll-like receptor 3 in overcoming cancer immunoediting
|
5K22CA122828-03
|
$162,035
|
$16,204
|
Bell, Jessica
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Mechanism of SHeA2 Action in Ovarian Cancer
|
5R01CA106713-05
|
$272,533
|
$272,533
|
BENBROOK, DORIS
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
RECRUITMENT OF BONE MARROW HEMATOPOIETIC STEM CELLS TO TUMORS
|
1R15CA137499-01
|
$221,250
|
$221,250
|
Benencia, Fabian
|
OHIO UNIVERSITY ATHENS
|
|
Tumor Host Range Mutants of Polyoma and Their Targets
|
5R01CA092520-09
|
$634,992
|
$634,992
|
BENJAMIN, THOMAS
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$3,736
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$3,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$4,301
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$350,667
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
|
1K05CA136967-01A1
|
$131,592
|
$6,580
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04021
|
$64,057
|
$4,484
|
Berrington, Amy
|
DCEG (NCI)
|
|
The Use of Transcriptional Factors as Targets and Agents in Carcinogenesis
|
ZIA SC 000165
|
$137,617
|
$34,404
|
Birrer, Michael
|
CCR (NCI)
|
|
The Molecular Genetics of Gynecologic Cancers
|
ZIA SC 000181
|
$206,425
|
$61,928
|
Birrer, Michael
|
CCR (NCI)
|
|
Modulation of tumor-associated macrophage phenotype by S1P receptors
|
1F32CA142117-01
|
$50,054
|
$50,054
|
Blaho, Victoria
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
Total relevant funding to Ovarian Cancer for this search: $110,121,501
|